Literature DB >> 32043151

Cancer Rehabilitation Publications (2008-2018) With a Focus on Physical Function: A Scoping Review.

Shana E Harrington1, Nicole L Stout2, Elizabeth Hile3, Mary Insana Fisher4, Melissa Eden5, Victoria Marchese6, Lucinda A Pfalzer7.   

Abstract

BACKGROUND: Cancer rehabilitation research has accelerated over the last decade. However, closer examination of the published literature reveals that the majority of this work has focused on psychological interventions and cognitive and behavioral therapies. Recent initiatives have aggregated expert consensus around research priorities, highlighting a dearth in research regarding measurement of and interventions for physical function. Increasingly loud calls for the need to address the myriad of physical functional impairments that develop in people living with and beyond cancer have been published in the literature. A detailed survey of the landscape of published research has not been reported to our knowledge.
PURPOSE: This scoping review systematically identified literature published between 2008 and 2018 related to the screening, assessment, and interventions associated with physical function in people living with and beyond cancer. DATA SOURCES: PubMed and CINAHL were searched up to September 2018. STUDY SELECTION: Study selection included articles of all levels of evidence on any disease stage and population. A total of 11,483 articles were screened for eligibility, 2507 full-text articles were reviewed, and 1055 articles were selected for final inclusion and extraction. DATA EXTRACTION: Seven reviewers recorded type of cancer, disease stage, age of participants, phase of treatment, time since diagnosis, application to physical function, study design, impairments related to physical function, and measurement instruments used. DATA SYNTHESIS: Approximately one-third of the articles included patients with various cancer diagnoses (30.3%), whereas the rest focused on a single cancer, most commonly breast (24.8%). Most articles (77%) measured physical function following the completion of active cancer treatment with 64% representing the assessment domain. The most commonly used measures of physical function were the Medical Outcomes Study 36-Item Health Survey Questionnaire (29%) and the European Organization for Research and Treatment of cancer Quality of Life Questionnaire-Cancer 30 (21.5%). LIMITATIONS: Studies not written in English, study protocols, conference abstracts, and unpublished data were excluded.
CONCLUSIONS: This review elucidated significant inconsistencies in the literature regarding language used to define physical function, measurement tools used to characterize function, and the use of those tools across the cancer treatment and survivorship trajectory. The findings suggested that physical function in cancer research is predominantly measured using general health-related quality-of-life tools rather than more precise functional assessment tools. Interdisciplinary and clinician-researcher collaborative efforts should be directed toward a unified definition and assessment of physical function.
© 2020 American Physical Therapy Association.

Entities:  

Mesh:

Year:  2020        PMID: 32043151      PMCID: PMC8204886          DOI: 10.1093/ptj/pzz184

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  62 in total

1.  Advancing the standard of cancer care.

Authors:  Robert W Carlson
Journal:  J Natl Compr Canc Netw       Date:  2013-05       Impact factor: 11.908

Review 2.  Physical and psychological long-term and late effects of cancer.

Authors:  Kevin D Stein; Karen L Syrjala; Michael A Andrykowski
Journal:  Cancer       Date:  2008-06-01       Impact factor: 6.860

Review 3.  Delivering tailored surgery to older cancer patients: Preoperative geriatric assessment domains and screening tools - A systematic review of systematic reviews.

Authors:  M G Huisman; M Kok; G H de Bock; B L van Leeuwen
Journal:  Eur J Surg Oncol       Date:  2016-06-21       Impact factor: 4.424

Review 4.  Qualitative meta-synthesis of survivors' work experiences and the development of strategies to facilitate return to work.

Authors:  Mary Stergiou-Kita; Alisa Grigorovich; Victrine Tseung; Elizabeth Milosevic; Debbie Hebert; Stephanie Phan; Jennifer Jones
Journal:  J Cancer Surviv       Date:  2014-07-04       Impact factor: 4.442

5.  Developing High-Quality Cancer Rehabilitation Programs: A Timely Need.

Authors:  Catherine M Alfano; Andrea L Cheville; Karen Mustian
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

Review 6.  Return to work among breast cancer survivors: A literature review.

Authors:  Yuanlu Sun; Cheryl L Shigaki; Jane M Armer
Journal:  Support Care Cancer       Date:  2016-11-21       Impact factor: 3.603

Review 7.  A Bibliometric Analysis of the Landscape of Cancer Rehabilitation Research (1992-2016).

Authors:  Nicole L Stout; Catherine M Alfano; Christopher W Belter; Ralph Nitkin; Alison Cernich; Karen Lohmann Siegel; Leighton Chan
Journal:  J Natl Cancer Inst       Date:  2018-08-01       Impact factor: 13.506

8.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Authors:  Ethan Basch; Allison M Deal; Mark G Kris; Howard I Scher; Clifford A Hudis; Paul Sabbatini; Lauren Rogak; Antonia V Bennett; Amylou C Dueck; Thomas M Atkinson; Joanne F Chou; Dorothy Dulko; Laura Sit; Allison Barz; Paul Novotny; Michael Fruscione; Jeff A Sloan; Deborah Schrag
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

9.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.

Authors:  Andrea C Tricco; Erin Lillie; Wasifa Zarin; Kelly K O'Brien; Heather Colquhoun; Danielle Levac; David Moher; Micah D J Peters; Tanya Horsley; Laura Weeks; Susanne Hempel; Elie A Akl; Christine Chang; Jessie McGowan; Lesley Stewart; Lisa Hartling; Adrian Aldcroft; Michael G Wilson; Chantelle Garritty; Simon Lewin; Christina M Godfrey; Marilyn T Macdonald; Etienne V Langlois; Karla Soares-Weiser; Jo Moriarty; Tammy Clifford; Özge Tunçalp; Sharon E Straus
Journal:  Ann Intern Med       Date:  2018-09-04       Impact factor: 25.391

10.  Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study.

Authors:  Anaïs Farcet; Laure de Decker; Vanessa Pauly; Frédérique Rousseau; Howard Bergman; Catherine Molines; Frédérique Retornaz
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

View more
  6 in total

Review 1.  Assessment of Cancer-Associated Cachexia - How to Approach Physical Function Evaluation.

Authors:  Julia Fram; Caroline Vail; Ishan Roy
Journal:  Curr Oncol Rep       Date:  2022-03-19       Impact factor: 5.075

2.  Can Steps per Day Reflect Symptoms in Children and Adolescents Undergoing Cancer Treatment?

Authors:  Janice S Withycombe; Molly McFatrich; Pamela S Hinds; Antonia Bennett; Li Lin; Scott H Maurer; Nicole R Lucas; Courtney M Mann; Sharon M Castellino; Justin N Baker; Bryce B Reeve
Journal:  Cancer Nurs       Date:  2022-02-05       Impact factor: 2.760

3.  Physical function measurement in older long-term cancer survivors.

Authors:  Jennifer Blackwood; Kateri Rybicki
Journal:  J Frailty Sarcopenia Falls       Date:  2021-09-01

Review 4.  Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health-a Scoping Review.

Authors:  Monica Pinto; Dario Calafiore; Maria Carmela Piccirillo; Massimo Costa; Ozden Ozyemisci Taskiran; Alessandro de Sire
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

5.  Responsiveness and interpretation of the PROMIS Cancer Function Brief 3D Profile.

Authors:  Sean R Smith; Mary Vargo; David S Zucker; Samman Shahpar; Lynn H Gerber; Maryanne Henderson; Gina Jay; Andrea L Cheville
Journal:  Cancer       Date:  2022-07-05       Impact factor: 6.921

6.  Variability in physical function for patients living with breast cancer during a 12-week exercise program.

Authors:  Courtni Soucy; Danielle R Bouchard; Travis Hrubeniuk; Martin Sénéchal
Journal:  Support Care Cancer       Date:  2021-07-06       Impact factor: 3.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.